Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 28,466 | 27,500 | 22,655 | 28,067 | 23,438 |
| Cost of Goods | 10,179 | 10,004 | 8,493 | 10,146 | 8,203 |
| Gross Profit | 18,287 | 17,496 | 14,162 | 17,921 | 15,235 |
| Operating Expenses | 16,770 | 17,473 | 14,543 | 18,156 | 31,564 |
| Operating Income | 1,696 | 27 | 112 | -89 | -16,126 |
| Other Income | 1,057 | 1,221 | 2,014 | 792 | 931 |
| Pre-tax Income | 2,753 | 1,248 | 2,126 | 703 | -15,195 |
| Income Tax | -42,351 | 62 | -173 | 82 | 126 |
| Net Income Continuous | 45,104 | 1,186 | 2,299 | 621 | -15,321 |
| Net Income Discontinuous | N/A | N/A | 8,771 | N/A | -517 |
| Net Income | $45,104 | $1,186 | $11,070 | $621 | $-15,838 |
| EPS Basic Total Ops | 0.92 | 0.02 | 0.24 | 0.01 | -0.33 |
| EPS Basic Continuous Ops | 0.92 | 0.02 | 0.05 | 0.01 | -0.32 |
| EPS Basic Discontinuous Ops | N/A | N/A | 0.19 | N/A | -0.01 |
| EPS Diluted Total Ops | 0.91 | 0.02 | 0.23 | 0.01 | -0.33 |
| EPS Diluted Continuous Ops | 0.91 | 0.02 | 0.05 | 0.01 | -0.32 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.18 | N/A | -0.01 |
| EPS Diluted Before Non-Recurring Items | 0.04 | 0.04 | 0.04 | 0.04 | 0.00 |
| EBITDA(a) | $2,505 | $726 | $698 | $1,246 | $-14,744 |